{"id":370,"date":"2019-10-03T12:00:23","date_gmt":"2019-10-03T12:00:23","guid":{"rendered":"https:\/\/www.bioevents.net\/fibromyalgia2021\/?page_id=370"},"modified":"2024-02-08T12:01:17","modified_gmt":"2024-02-08T12:01:17","slug":"dear-colleague-echoy","status":"publish","type":"page","link":"https:\/\/echoy2024.com\/dear-colleague-echoy\/","title":{"rendered":"Dear Colleagues"},"content":{"rendered":"
Dear Colleagues,<\/span><\/p>\n It is our great pleasure to welcome you to\u00a0The European Conference on Haematology-Oncology <\/strong>which will take place 28-29 May 2024 in London. We will bring together distinguished leaders in the field of haemato-oncology to deliver lectures that are idea focused. The program of the upcoming congress covers topics from all fields of Haemato-oncology i.e myeloid malignancies, lymphoid malignancies and plasma cell disorders and other related collateral topics.<\/span><\/p>\n This Conference will welcome hematologists, healthcare clinicians, hematologic oncologists, medical, radiation and surgical oncologists, physicians, oncology nurses, nurse practitioners, occupational therapists, researchers, pharmacists and other healthcare professionals working in the fields of oncology and hematology.<\/span><\/p>\n The Conference will focus on the following key areas:<\/span><\/p>\n Join us as a Sponsor or Exhibitor and benefit from maximum visibility and exposure to a broader audience.<\/span><\/p>\n We look forward to meeting you at T<\/strong>he European Conference on Haematology-Oncology (ECHOy)<\/strong> in the vibrant and wonderful city of London.<\/span><\/p>\n Sincerely,<\/span><\/p>\n <\/p>\n <\/p>\n Dr. Sunil Gupta FRCP (UK), FRCPath (UK), Executive MBA (Hult Ashridge), Chartered Manager, FCMI (UK)<\/span><\/em><\/span> Dear Colleagues, It is our great pleasure to welcome you to\u00a0The European Conference on Haematology-Oncology which will take place 28-29 May 2024 in London. The aims of this conference are: Update on Haemato-oncology topics Understand the fast changing landscape in the era of CART and Bispecific Is transplant still a viable option in myeloma and […]<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-370","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\n
\n<\/strong><\/span>
\nThe aims of this conference are:<\/span><\/p>\n\n
\n
\n<\/strong><\/span>Conference Chair<\/span><\/span><\/p>\n
\nConsultant Haematologist<\/span><\/em><\/span>
\nHonorary Senior Clinical Lecturer (GKT School of Medicine)<\/span><\/em><\/span>
\nCPD Approver and Advisor -The Federation of Royal Colleges of Physicians (UK)<\/span><\/em><\/span>
\nLewisham and Greenwich NHS Trust<\/span><\/em><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"